JG
SUPN icon

Jefferies Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Jefferies Group’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$2.67K – 1979
2021
Q3 		$2.67K Buy
+100
New +$2.68K ﹤0.01% 1669
2021
Q2 		– Sell
-112,500
Closed -$2.95M – 1970
2021
Q1 		$2.95M Buy
+112,500
New +$3.15M 0.03% 557
2019
Q4 		– Sell
-34,023
Closed -$935K – 2972
2019
Q3 		$935K Buy
34,023
+31,530
+1,265% +$934K 0.01% 1545
2019
Q2 		$82K Sell
2,493
-45,148
-95% -$1.55M ﹤0.01% 2311
2019
Q1 		$1.67M Buy
+47,641
New +$1.77M 0.01% 1003
2018
Q4 		– Sell
-31,340
Closed -$1.58M – 2541
2018
Q3 		$1.58M Buy
31,340
+26,535
+552% +$1.31M 0.01% 1090
2018
Q2 		$288K Buy
+4,805
New +$249K ﹤0.01% 1868
2018
Q1 		– Sell
-9,652
Closed -$385K – 2691
2017
Q4 		$385K Buy
+9,652
New +$381K ﹤0.01% 1869
2017
Q3 		– Sell
-25,000
Closed -$1.08M – 2602
2017
Q2 		$1.08M Buy
25,000
+24,429
+4,278% +$869K 0.01% 1259
2017
Q1 		$18K Buy
+571
New +$15.3K ﹤0.01% 2239
2015
Q3 		– Sell
-162
Closed -$3K – 2977
2015
Q2 		$3K Sell
162
-34,828
-100% -$496K ﹤0.01% 3103
2015
Q1 		$423K Buy
+34,990
New +$331K ﹤0.01% 1443
2014
Q4 		– Sell
-508,536
Closed -$4.42M – 2314
2014
Q3 		$4.42M Buy
508,536
+258,064
+103% +$2.33M 0.03% 462
2014
Q2 		$2.74M Buy
+250,472
New +$2.23M 0.02% 539

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Jefferies Group's SUPN Position: Q4 2021 in Review

Jefferies Group sold out of Supernus Pharmaceuticals (SUPN) in Q4 2021, closing a stake of 100 shares — an estimated $2.67K sold.

Jefferies Group first reported a position in SUPN in Q2 2014 and held it in 14 quarters. The position peaked at $4.42M in Q3 2014. 235 funds tracked by Wall St. Rank hold SUPN as of Q4 2021.

  • Jefferies Group reported no remaining Supernus Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Jefferies Group sold 100 Supernus Pharmaceuticals shares in Q4 2021, an estimated $2.67K.
  • Jefferies Group first reported a position in Supernus Pharmaceuticals in Q2 2014 and held it in 14 quarters.
  • Jefferies Group's Supernus Pharmaceuticals position peaked at $4.42M in Q3 2014.
  • 235 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2021.

Based on Jefferies Group's 13F filing for Q4 2021, filed 14 Feb 2022.